What problem is Docola trying to solve?

Docola targets the inefficiency in healthcare communication. Specifically, it addresses the fact that primary care consultations last less than 5 minutes for half the world's population and the projected $6.2 trillion in health spending by 2028. By using asynchronous tools, they aim to provide the 'personal touch' without requiring real-time physician presence for every interaction.

How does Docola differentiate itself from standard telehealth?

Unlike traditional synchronous video calls (like Zoom or Teladoc), Docola emphasizes 'asynchronous' interactions. Slide 4 highlights that they act as a single point-of-contact for patients to aggregate information from multiple clinicians, positioning the platform as a hub for patient education rather than just a video conferencing tool.

What is the current traction of the company?

The deck is light on hard traction metrics. Slide 1 shows a mobile mockup with '1.3K Total Patients' and '83 Total Hours Saved,' but these appear to be placeholder or illustrative figures within a UI design. Slide 6 provides social proof through testimonials from medical directors and coordinators, suggesting the product is in use at several medical centers.

Who are the key members of the leadership team?

The team is led by Eran Kabakov (CEO/CTO), a PT with 35 years in patient care. The leadership includes Geri Lynn Baumblatt (Chief Engagement Officer), formerly of Emmi Solutions; Itay Tsabari (CFO), with experience at Motorola and Deloitte; Dr. Jonathan Ascher (CMO); and Tomer Kabakov (COO), a serial entrepreneur who has co-founded six companies.

What is missing from this pitch deck?

The deck is missing several essential components for a professional fundraise: a business model (how they make money), a competitive landscape analysis, detailed financials/projections, and a clear funding ask. Without these, it functions more as a product overview or a 'vision' deck than a complete investment memorandum.

Docola Pitch Deck (2022): 12-Slide Breakdown

See all 12 slides of the Docola pitch deck — a 2022 deck in Telehealth — with a slide-by-slide teardown of what the deck does well and where it falls short.

Docola’s pitch deck focuses on the 'Telehealth-Plus Platform,' an asynchronous communication tool designed to streamline patient education and follow-up. The deck leans heavily on macroeconomic pressures, such as the projected shortage of 124,000 physicians by 2034 and the rise of national health spending to $6.2 trillion by 2028. While the team slide showcases deep clinical and operational expertise, the deck lacks critical financial data, including a business model, unit economics, and a specific funding ask. The solution is positioned as a 'global' single point-of-contact for patients, yet…

Key takeaways

The deck identifies a massive physician shortage of 124,000 by 2034 as a primary market driver on Slide 2.
Docola positions itself as an 'asynchronous telehealth' platform for curated patient education and follow-up on Slide 3.
The platform claims to have saved 83 total hours and managed 1.3K total patients according to the mockup on Slide 1.
The team is highly experienced, featuring a CEO with 35 years in patient care and a COO who co-founded 6 tech companies on Slide 5.
Differentiation is built on being a 'single point-of-contact' for patients to view info from multiple clinicians on Slide 4.
The deck includes high-level testimonials from institutions like the Erie County Medical Center and Cincinnati Children's Hospital on Slide 6.
There is no mention of revenue, pricing models, or customer acquisition costs in the provided slides.
The deck lacks a 'The Ask' slide, leaving the intended funding amount and use of proceeds unknown.

Docola Pitch Deck Analysis

Docola is positioning itself at the intersection of patient education and telehealth. In an era where physician burnout is at an all-time high and patient face-time is dwindling, Docola proposes an asynchronous solution to maintain the quality of care without increasing the time burden on clinicians. The deck is structured to highlight the macro-crisis in healthcare before introducing their 'Telehealth-Plus' platform as the remedy.

Slide 1: Title and Initial Mockup

The cover slide introduces the brand with the tagline "Communicating the Future of Health." The most significant element here is the mobile phone mockup, which provides the only glimpse into the platform's metrics. The screen displays: "83 Total Hours Saved," "1.3K Total Patients," "156 Active Patients," "244 Total Prescriptions," and "274 Courses." These figures suggest the platform is designed to track efficiency and patient engagement. However, as this is a mockup on a title slide, it is unclear if these represent real-time aggregate data for the company or a sample dashboard for a single clinic.

Slide 2: The Challenges

Docola uses this slide to establish the 'Why Now?' of their business. They cite three heavy-hitting statistics to frame the problem:

"America will face a shortage of up to 124,000 physicians by 2034" (Source: Association of American Medical Colleges). · "National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028" (Source: CMS.gov). · "Primary care consultations last less than 5 minutes for half the world's population" (Source: British Medical Journal).

By leading with these, Docola argues that the current healthcare model is unsustainable and that a technological intervention is mandatory to prevent a total collapse of patient-provider communication.

Slide 3: The Solution

The solution slide defines the product category: "asynchronous telehealth." The platform is described as a way to deliver "clinician curated, patient education, communication, support and follow up." They name their product the "Telehealth-Plus Platform" and claim it can transform healthcare through "personalized digital interactions before, during, and after medical appointments." This suggests the product is not a replacement for the doctor's visit, but a digital wrapper that extends the visit's value.

Slide 4: Differentiation

This slide attempts to carve out Docola's unique space in the market. They list three core beliefs:

"We are a global solution" : Suggesting scalability beyond the US market. · "We enhance the relationships between patients and clinicians" : Positioning themselves as a facilitator rather than a disruptor of the traditional doctor-patient bond. · "We are a single point-of-contact for patients to view information from multiple clinicians" : This is the most important technical differentiator, implying a patient-centric portal that aggregates data across different providers.

Slide 5: The Team

The team slide is a strong point for Docola, showcasing a mix of clinical, technical, and financial expertise. Key members include:

Eran Kabakov, PT (CEO & CTO) : 35 years in patient care and 20 years in digital health. · Geri Lynn Baumblatt (Chief Engagement Officer) : 20 years in patient engagement, formerly Exec. Dir. at Emmi Solutions. · Itay Tsabari, MBA (CFO) : Former CFO at Copilot.CX and Finance Manager at Motorola Israel. · Jonathan Ascher, MD (CMO) : Director at New York Eye and Ear Infirmary. · Tomer Kabakov (COO) : 20 years in tech sales, co-founded 6 tech companies.

The presence of a Chief Engagement Officer is particularly relevant given the product's focus on patient education and communication.

Slide 6: Testimonials

The final slide in this set provides social proof through five quotes from healthcare professionals. Notable mentions include:

Joseph Caruana, MD from Erie County Medical Center, who notes a positive difference in "quality of life" in the practice. · Thomas H. Inge, MD from Cincinnati Children's Hospital, calling it a "tremendous addition" to patient education. · Sharon Krzyzanowski from Advent Health Celebration, who mentions the platform has "streamlined the process without losing that personal touch." · Paul G. Loberti from the Rhode Island Department of Health, expressing excitement about "new market horizons."

These testimonials suggest the product has been successfully piloted or implemented in large-scale hospital environments and state health departments.

What is Missing from the Docola Deck

While the vision and team are clear, the deck omits several critical components required for a successful fundraising round.

1. Business Model and Revenue Streams

There is no information regarding how Docola generates revenue. Is it a SaaS model charged per clinician? A per-patient-per-month (PPPM) fee? Or a licensing model for large hospital systems? Without a pricing strategy, investors cannot evaluate the potential for scale or the path to profitability.

2. Market Size (TAM/SAM/SOM)

While Slide 2 mentions the $6.2 trillion total health spending, it does not narrow down the specific addressable market for patient education software or asynchronous telehealth. Investors need to see the specific slice of the market Docola intends to capture.

3. Competitive Landscape

The telehealth space is crowded with giants like Teladoc and Amwell, as well as niche patient engagement tools. The deck does not provide a competitive matrix or a clear explanation of why a hospital would choose Docola over an integrated module within their existing Electronic Health Record (EHR) system like Epic or Cerner.

4. The Ask and Use of Funds

The most glaring omission is the lack of a funding request. The deck does not state how much capital is being raised, the valuation, or how the money will be spent (e.g., 50% engineering, 30% sales, 20% marketing). This makes it difficult to categorize the stage of the company (Seed vs. Series A).

What Founders Should Copy from This Deck

Despite the omissions, there are several elements that founders should emulate:

Macro-Problem Framing : Slide 2 does an excellent job of using authoritative sources (AAMC, CMS, BMJ) to prove that the problem is not just a nuisance, but a systemic crisis. · Role-Specific Team Highlights : Instead of just listing titles, the team slide highlights specific years of experience and relevant past companies (Motorola, Deloitte, Emmi Solutions), which builds immediate credibility. · Focus on 'Asynchronous' : By leaning into the word "asynchronous," Docola avoids being compared directly to the saturated market of live video telehealth providers. It defines a specific niche that solves a specific problem (clinician time). · Institutional Social Proof : The testimonials are not from anonymous users but from named directors and coordinators at reputable institutions like Cincinnati Children's and Advent Health. This is high-value validation for a B2B healthcare startup.

Frequently asked questions

What problem is Docola trying to solve?: Docola targets the inefficiency in healthcare communication. Specifically, it addresses the fact that primary care consultations last less than 5 minutes for half the world's population and the projected $6.2 trillion in health spending by 2028. By using asynchronous tools, they aim to provide the 'personal touch' without requiring real-time physician presence for every interaction.
How does Docola differentiate itself from standard telehealth?: Unlike traditional synchronous video calls (like Zoom or Teladoc), Docola emphasizes 'asynchronous' interactions. Slide 4 highlights that they act as a single point-of-contact for patients to aggregate information from multiple clinicians, positioning the platform as a hub for patient education rather than just a video conferencing tool.
What is the current traction of the company?: The deck is light on hard traction metrics. Slide 1 shows a mobile mockup with '1.3K Total Patients' and '83 Total Hours Saved,' but these appear to be placeholder or illustrative figures within a UI design. Slide 6 provides social proof through testimonials from medical directors and coordinators, suggesting the product is in use at several medical centers.
Who are the key members of the leadership team?: The team is led by Eran Kabakov (CEO/CTO), a PT with 35 years in patient care. The leadership includes Geri Lynn Baumblatt (Chief Engagement Officer), formerly of Emmi Solutions; Itay Tsabari (CFO), with experience at Motorola and Deloitte; Dr. Jonathan Ascher (CMO); and Tomer Kabakov (COO), a serial entrepreneur who has co-founded six companies.
What is missing from this pitch deck?: The deck is missing several essential components for a professional fundraise: a business model (how they make money), a competitive landscape analysis, detailed financials/projections, and a clear funding ask. Without these, it functions more as a product overview or a 'vision' deck than a complete investment memorandum.

Cover slide of the Docola pitch deck — 2022 — Docola pitch deck, slide 1 (2022)

Docola pitch deck: the facts

Company: Docola
Year: 2022
Slides: 12
Sector: Telehealth / Patient Education
Deck type: Pitch Deck

Docola pitch deck PDF

The full Docola deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Docola pitch deck was used for

This deck is a 12‑slide investor presentation for Docola, a Largo, Florida–based digital health company offering a free asynchronous care communication and patient education platform, delivered via its Telehealth‑Plus platform. The deck, dated around 2022, highlights Docola’s use of asynchronous telehealth and curated digital education to extend clinician communication before, during, and after appointments, aiming to address clinician shortages, short visits, and complex comorbidities. The stage and target raise for this specific deck are not disclosed in publicly available sources; the deck appears to precede or relate to Docola’s later plans to raise capital via a securities offering and potential IPO process, as reflected in subsequent SEC registration filings and investor materials.

Business model: Free care communication / asynchronous telehealth platform that consolidates free and low-cost patient education resources from nonprofit, government, and commercial organizations into an online marketplace, allowing providers to e‑prescribe education and communication to patients between visits.

Founders: Eran Kabakov
Headquarters: Largo, Florida, United States (801 West Bay Drive, Suite/Unit 506, Largo, FL 33770).
Industry: Digital health / telehealth / patient education.

What the Docola deck got right

Clear early usage traction with both patients and clinicians. The deck presents concrete traction metrics—approximately 55,000 patient users, 1,146 clinicians, and 273 content providers—with notes on organic growth driven by clinicians and account shelf life greater than three years, which signals early product–market fit and sustained usage.
Differentiated social‑good and free‑platform positioning. Docola’s positioning as a free care communication platform and social good organization that consolidates thousands of free and low‑cost educational resources from nonprofits, government, and commercial entities differentiates it from more traditional, paid patient education tools.
Strong problem–solution fit around time‑constrained care. The solution emphasizes asynchronous telehealth and education between visits, which directly addresses documented problems like short appointments, clinician understaffing, growing patient–clinician ratios, and complex comorbidities.
Forward‑looking use of AI and interactive content. By highlighting AI avatars and interactive solutions among its 273 content providers and referencing AI and machine learning for capacity expansion, the deck signals a forward‑looking approach to personalized digital interactions across the care continuum.
Third‑party validation through partnerships and programs. External materials, including collaborations with organizations like the Medical Education Institute and inclusion in KidneyX‑related content, provide independent validation that Docola’s platform is used for specific clinical education programs (e.g., CKD and COVID‑19).
Broad applicability across provider types and settings. The deck clearly articulates that accounts can serve multiple providers (1–6 per account) and that usage spans hospital systems, private practices, and both commercial and nonprofit providers, suggesting flexibility across healthcare settings.

What could have been stronger

Limited transparency and context around traction metrics. The deck’s user statistics (55,000 patients, 1,146 clinicians, 273 content providers) are reported as internal figures without external validation, cohort breakdowns, or time‑series charts, making it difficult for investors to assess growth rate, retention by segment, or quality of usage.
Lack of quantified clinical and economic outcomes. While the deck lists multiple problems—short visits, understaffing, complex comorbidities, value‑based care—it does not quantify the economic impact (e.g., dollars saved per patient, reduced readmissions, or time saved per clinician), nor does it present outcome data demonstrating that Docola materially improves health literacy or clinical outcomes.
Unclear AI/technology differentiation and defensibility. The slides highlight AI and machine learning and mention AI avatars and interactive solutions, but they do not clearly explain what is proprietary versus integrated third‑party tools, how AI is used operationally, or whether there are defensible technology moats beyond content aggregation.
Business model and monetization not fully articulated in the deck. Although Docola positions itself as a free care communication platform and social good organization, the deck text provided does not outline a clear revenue model, monetization strategy, or path to sustainability, leaving investors uncertain how the company plans to generate and scale recurring revenue.
Limited competitive and regulatory context. The deck positions Docola as a single global platform and implies broad adoption but does not specify geographic footprint, regulatory status (e.g., HIPAA or other compliance beyond generic claims), or competitive positioning versus other patient engagement and telehealth platforms.

How an investor would read this deck

What draws attention

The deck reports meaningful early usage metrics, including approximately 55,000 patient users, 1,146 clinicians, and 273 content providers, suggesting organic adoption across hospitals, private practices, and content partners.
Docola’s positioning as a free, social‑good‑oriented care communication platform that aggregates high‑quality resources from nonprofit, government, and commercial sources differentiates it from purely commercial patient engagement tools.
The focus on asynchronous telehealth and education between visits addresses a clear pain point—time‑limited appointments and clinician shortages—in a way that can complement synchronous telemedicine rather than compete with it.
Partnerships and recognition, such as collaborations with the Medical Education Institute on CKD/COVID‑19 content and mention in KidneyX materials, provide third‑party validation of the platform’s utility in specific clinical domains.

Risks that stand out

The free‑platform positioning may limit revenue options or require careful balancing between monetization (e.g., licensed content, enterprise offerings) and maintaining trust as a social‑good provider.
Dependence on third‑party educational content and partnerships could pose risks if key content providers change licensing terms, withdraw content, or launch competing platforms.
Competition from large EHR vendors, telehealth platforms, and hospital systems’ own education tools may challenge Docola’s ability to remain the primary point‑of‑contact for patient education.
Scaling AI and machine‑learning features while maintaining clinical accuracy and regulatory compliance could increase operational complexity and require significant investment in quality assurance and governance.

Questions this deck invites

How have Docola’s user metrics (patients, clinicians, content providers) evolved since the snapshot in the deck, and what are the key cohort retention and engagement statistics by specialty and organization type?
What validated evidence exists—such as peer‑reviewed studies, quality improvement projects, or controlled pilots—that Docola’s platform improves patient understanding, adherence, or clinical outcomes and reduces costs for providers?
What is Docola’s detailed revenue model (e.g., premium content licensing, enterprise contracts, sponsorships) and how does that align with its social‑good and free‑platform positioning?
How does Docola differentiate itself from other patient education and engagement platforms (including EHR‑integrated tools), and what elements of its technology or content curation are proprietary or defensible?
What is the current regulatory and security posture (e.g., HIPAA, data handling, content vetting), and how does Docola manage patient privacy given its free access model and web‑based distribution?

What founders can take from the Docola deck

Articulating a clear, compelling use of asynchronous telehealth to address clinician time constraints and patient complexity can strongly frame a digital health narrative around real workflow problems.
Including concrete user metrics (patients, clinicians, content providers) in a deck helps ground the story in traction, even if investors will still probe for deeper engagement and retention data.
Positioning a platform as a social good initiative with a free core offering can differentiate it in healthcare, but it also underscores the need to explicitly explain monetization to investors.
Partnering with credible nonprofits and medical education organizations, and being featured in programs like KidneyX initiatives, can provide third‑party validation that bolsters a pitch.
Highlighting how a platform extends care between visits, rather than replacing existing clinical encounters, can make adoption seem less disruptive and more complementary for providers.
Explicitly describing the role of AI and interactive content, including what is proprietary, can help clarify differentiation and avoid vague “AI‑enabled” claims.

Docola pitch deck: common questions

What is Docola and what does it do?

Docola is a digital health and patient education company that offers a free asynchronous care communication platform, allowing clinicians and healthcare organizations to e‑prescribe educational resources and communications to patients between visits. Its platform consolidates thousands of free and low‑cost patient education resources from nonprofit, government, and commercial organizations into an online marketplace accessed via web.

How does Docola’s platform work in practice?

Docola’s platform enables clinicians to send personalized education, decision aids, and other resources to patients before, between, and after visits, track whether patients engage with those materials, and support ongoing communication outside time‑limited visits. According to its investor and company descriptions, the platform is offered as a free care communication service to hospitals, clinics, healthcare providers, and patients, with some premium or licensed content available for a fee.

What user traction does the Docola pitch deck report?

According to the pitch deck shared on SlideShare and summarized descriptions, Docola reported organic usage of about 55,000 patient users and 1,146 clinician users, with accounts serving on average 1–6 healthcare providers and a typical account shelf life greater than three years. The same slide notes 273 content providers, including AI avatars and interactive solutions, with all data sourced from the company’s internal databases and client surveys.

Has Docola raised funding, and is there information about the round related to this deck?

Publicly available information, including an S‑1/A registration statement and IPO commentary, indicates that Docola has pursued a capital‑raising process via a public securities offering, positioning itself as a social good organization offering a free care communication platform. However, specific details about a distinct private funding round tied to the 2022 deck—such as round type, amount raised, and named investors—are not disclosed in accessible public sources, so they cannot be confirmed.

Who are Docola’s main customers and users?

The pitch deck describes key users as hospital systems, private practices, commercial and nonprofit providers, and clinics that often focus on a single medical specialty, along with 273 content providers including AI‑based and interactive education tools. External sources similarly note that Docola targets healthcare providers such as physicians, clinics, hospitals, and case managers who need to deliver and track patient education at scale.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

Docola pitch deck slides

Docola pitch deck slide 1 of 12 — Docola pitch deck — slide 1 of 12

Docola pitch deck slide 2 of 12 — Docola pitch deck — slide 2 of 12

Docola pitch deck slide 3 of 12 — Docola pitch deck — slide 3 of 12

Docola pitch deck slide 4 of 12 — Docola pitch deck — slide 4 of 12

Docola pitch deck slide 5 of 12 — Docola pitch deck — slide 5 of 12

Docola pitch deck slide 6 of 12 — Docola pitch deck — slide 6 of 12

What each slide of the Docola pitch deck says

Slide 1

Slide 2

Disclaimers This presentation shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This document contains highly confidential information and is solely for informational purposes for the person to whom it is delivered (the "Recipient"). Recipient and its affiliates and agents must hold this document and any oral information provided in connection with this document, as well as any information derived by…

Slide 3

. Challenges “America will face a shortage of F up to 124,000 physicians by 2034” gd \ Association of American Medical Colleges F | - « oN “National health spending is projected S * / A to grow at an average annual rate of “& / 5.4 percent for 2019-28 and to reach = 8 x o> $6.2 trillion by 2028” A i 7 Z CMS.gov NHE Fact Sheet | 7 4 “Primary care consultations last less > /d than 5 minutes for half the ol fl y world’s population” i y : F 4 British Medical Journal RB % 4 fi i 5 he J

Slide 4

Breakdowns Appointment times are too short Clinics and hospitals are understaffed The Patient-Clinician ratio is rapidly growing Patients present with complex comorbidities Treatment plans require educated patients Value based healthcare is resource consuming Challenges Our Solutions Intend To: - Extend clinicians' knowledge beyond the point of care - Enhance operational efficiency - Enable clinicians to serve more patients in less time - Improve patient & family education for better self care - Increase health literacy and self care education - Expand capacity using Al and machine learning

Slide 5

Solution Utilize asynchronous telehealth to deliver clinician curated, patient education, communication, support and follow up We believe Docola's proprietary Telehealth-Plus Platform can transform healthcare with personalized digital interactions before, during, and after medical appointments

Slide 6

User Statistics User Accounts (Organic Growth) Statistics 4 weeks, Avg time on platform 55,000 Patients easeearent Patient-user growth driven by clinicians Account serves on average 1-6 healthcare providers A=A Account shelf-life >3 years 1146 CIInICIanS Hospital systems and private practice Commercial, non-for-profit, and private providers . Many focus on single medical specialty 273 Content prowders Include Al avatars and Interactive solutions *All data on this slide obtained from company's database queries, records, and client surveys

Slide 7

Differentiation We believe that: We are a global We enhance the We are a single solution relationships point-of-contact for between patients patients to view and clinicians information from multiple clinicians

Slide text above is read directly from the Docola deck PDF embedded on this page.

Related fundraising guides (24)

Decks from the same year (1)

2022 pitch deck examples

Browse companies alphabetically (1)

Pitch decks from companies starting with D

More pitch deck teardowns (16)

Recently published pitch deck teardowns (12)

Fundraising library · Pitch deck examples · Investor directory · Founder database